[Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000818:Animals; D004176:Dipyridamole / Q000494:pharmacology; D004974:Etazolate / Q000494:pharmacology; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D010208:Papaverine / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D013806:Theophylline / Q000494:pharmacology
D007527:Isoenzymes; D004176:Dipyridamole; D013806:Theophylline; D010208:Papaverine; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D004974:Etazolate
Intérêt pharmacologique des inhibiteurs de la nucléotide cyclique phosphodiestérase.